Development of vaccines and treatments for novel coronavirus
11. Februar 2020 – The European Medicines Agency (EMA) supports and takes concrete actions for the development of vaccines and treatments for the novel coronavirus. EMA has activated its plan for managing health threats. The Agency is surveying the landscape for potential antivirals or vaccines to treat or prevent infections. EMA furthermore collaborates and exchanges information with EU public health authorities. For further information, see here.